These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28621319)

  • 21. Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.
    Rodríguez-Zarco E; Vallejo-Benítez A; Umbría-Jiménez S; Pereira-Gallardo S; Pabón-Carrasco S; Azueta A; González-Cámpora R; Espinal PS; García-Escudero A
    Actas Urol Esp; 2017 Oct; 41(8):529-534. PubMed ID: 28285791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.
    Liu Q; Russell MR; Shahriari K; Jernigan DL; Lioni MI; Garcia FU; Fatatis A
    Cancer Res; 2013 Jun; 73(11):3297-305. PubMed ID: 23536554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
    Tsai HK; Lehrer J; Alshalalfa M; Erho N; Davicioni E; Lotan TL
    BMC Cancer; 2017 Nov; 17(1):759. PubMed ID: 29132337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of neuroendocrine prostate cancer.
    Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
    Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
    Hansel DE; Nakayama M; Luo J; Abukhdeir AM; Park BH; Bieberich CJ; Hicks JL; Eisenberger M; Nelson WG; Mostwin JL; De Marzo AM
    Prostate; 2009 May; 69(6):603-9. PubMed ID: 19125417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
    Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
    Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
    [No Abstract]   [Full Text] [Related]  

  • 27. The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.
    Qi J; Pellecchia M; Ronai ZA
    Oncotarget; 2010 Sep; 1(5):379-85. PubMed ID: 21037926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small cell neuroendocrine carcinoma of the esophagus: report of 6 cases with immunohistochemical and molecular genetic analysis of KIT and PDGFRA.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(3):485-91. PubMed ID: 23411580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT.
    Liu YN; Chen WY; Yeh HL; Chen WH; Jiang KC; Li HR; Dung PVT; Chen ZQ; Lee WJ; Hsiao M; Huang J; Wen YC
    Sci Signal; 2024 Jun; 17(840):eadc9142. PubMed ID: 38861615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum calcitonin in small cell carcinoma of the prostate.
    Sim SJ; Glassman AB; Ro JY; Lee JJ; Logothetis CJ; Liu FJ
    Ann Clin Lab Sci; 1996; 26(6):487-95. PubMed ID: 8908318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.
    Patel SJ; Molinolo AA; Gutkind S; Crawford NP
    PLoS One; 2013; 8(4):e61848. PubMed ID: 23620793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma.
    Perez-Balaguer A; Ortiz-Martínez F; García-Martínez A; Pomares-Navarro C; Lerma E; Peiró G
    Breast Cancer Res Treat; 2015 Sep; 153(2):465-74. PubMed ID: 26298189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
    Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.
    Zaidi S; Park J; Chan JM; Roudier MP; Zhao JL; Gopalan A; Wadosky KM; Patel RA; Sayar E; Karthaus WR; Kates DH; Chaudhary O; Xu T; Masilionis I; Mazutis L; Chaligné R; Obradovic A; Linkov I; Barlas A; Jungbluth AA; Rekhtman N; Silber J; Manova-Todorova K; Watson PA; True LD; Morrissey C; Scher HI; Rathkopf DE; Morris MJ; Goodrich DW; Choi J; Nelson PS; Haffner MC; Sawyers CL
    Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2322203121. PubMed ID: 38968122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma.
    Wang CC; De Marzo AM; Lotan TL; Epstein JI
    Hum Pathol; 2015 Apr; 46(4):554-7. PubMed ID: 25656929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.
    Schelling LA; Williamson SR; Zhang S; Yao JL; Wang M; Huang J; Montironi R; Lopez-Beltran A; Emerson RE; Idrees MT; Osunkoya AO; Man YG; Maclennan GT; Baldridge LA; Compérat E; Cheng L
    Hum Pathol; 2013 Oct; 44(10):2227-33. PubMed ID: 23850495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
    Bell PD; Huber AR; Agostini-Vulaj D
    Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.
    Tan HL; Sood A; Rahimi HA; Wang W; Gupta N; Hicks J; Mosier S; Gocke CD; Epstein JI; Netto GJ; Liu W; Isaacs WB; De Marzo AM; Lotan TL
    Clin Cancer Res; 2014 Feb; 20(4):890-903. PubMed ID: 24323898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling a lethal prostate cancer variant with small-cell carcinoma features.
    Tzelepi V; Zhang J; Lu JF; Kleb B; Wu G; Wan X; Hoang A; Efstathiou E; Sircar K; Navone NM; Troncoso P; Liang S; Logothetis CJ; Maity SN; Aparicio AM
    Clin Cancer Res; 2012 Feb; 18(3):666-77. PubMed ID: 22156612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small cell carcinoma of the prostate expressing prostate-specific antigen and showing syndrome of inappropriate secretion of antidiuretic hormone: an autopsy case report.
    Kawai S; Hiroshima K; Tsukamoto Y; Tobe T; Suzuki H; Ito H; Ohwada H; Ito H
    Pathol Int; 2003 Dec; 53(12):892-6. PubMed ID: 14629757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.